A carregar...
T26. CLINICAL OUTCOME ASSESSMENTS FOR TRIALS IN COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA
BACKGROUND: For clinical development programs in cognitive impairment associated with schizophrenia (CIAS), it has been stated that significant improvement on a cognitive performance endpoint would be necessary, but not sufficient, for drug approval. In addition, regulators require improvement on a...
Na minha lista:
| Publicado no: | Schizophr Bull |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6455558/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbz019.306 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|